Viewing StudyNCT04021368



Ignite Creation Date: 2024-05-06 @ 1:26 PM
Last Modification Date: 2024-10-26 @ 1:14 PM
Study NCT ID: NCT04021368
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-14
First Post: 2019-07-12

Brief Title: RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Sponsor: Ryvu Therapeutics SA
Organization: Ryvu Therapeutics SA

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
High-risk Myelodysplastic Syndrome
Keywords:
Name View
Acute Myeloid Leukemia View
Myelodysplastic Syndrome View
CDK819 Inhibitor View
RVU120 SEL120 View
Clinical Trial Phase Ib View